RxDoctor Payments DataLook up a doctor →

Gary Thomas, MD

Hematology & Oncology · Hilton Head Island, SCNPI 1043218316

Payments from drug & device makers

$99,891in general payments, 2019–2025

Across 674 payments — averaging $148.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$20K
  • E.r. Squibb & Sons, L.L.C.$17K
  • Bristol Myers Squibb$11K
  • Incyte Corporation$9K
  • Merck$5K
  • Pharmacosmos Therapeutics Inc.$4K
  • plus $34K from 54 others
$1,519in research payments, 2019–2025

Across 1 payment — averaging $1518.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen24$19,694
E.r. Squibb & Sons, L.L.C.61$17,159
Bristol Myers Squibb42$10,853
Incyte Corporation29$8,819
Merck61$4,651
Pharmacosmos Therapeutics Inc.10$4,183
AstraZeneca(2 entities)36$3,649
Puma Biotechnology, Inc.8$3,423
Avyxa Pharma, LLC5$3,389
Novartis24$2,833
Beigene USA, Inc.4$2,695
Eisai Inc.12$2,417
Pharmacyclics LLC, An Abbvie Company20$2,233
Bayer11$2,131
Gilead(2 entities)14$1,989
Seagen Inc.9$1,492
Pfizer34$677
Johnson & Johnson31$634
Beigene, Ltd.1$525
Lilly USA, LLC19$438
Sanofi14$422
Takeda Pharmaceuticals U.S.A., Inc.14$395
Athenex Pharmaceutical Division, LLC2$350
GSK12$260
Taiho Oncology, Inc.11$260
Genentech USA, Inc.11$242
Boehringer Ingelheim4$240
Daiichi Sankyo Inc.9$225
Regeneron Healthcare Solutions, Inc.12$218
Astellas Pharma US Inc7$216
Karyopharm Therapeutics Inc.5$203
Novocure GmbH1$200
Novocure Inc.3$177
Jazz Pharmaceuticals Inc.8$157
AbbVie8$153
AVEO Pharmaceuticals, Inc.6$150
Rigel Pharmaceuticals, Inc.6$143
Ipsen Biopharmaceuticals, Inc7$140
Array Biopharma Inc7$139
Beone Medicines USA, Inc.5$137
Verastem, Inc.2$129
Comsort, Inc1$100
Tempus AI, Inc2$97
Sobi, Inc5$97
Blueprint Medicines Corporation1$89
Exelixis Inc.5$85
Servier Pharmaceuticals LLC5$82
Pharmaessentia USA Corporation4$80
Adaptive Biotechnologies Corporation4$69
EMD Serono, Inc.4$62
Acrotech Biopharma Inc.3$61
Sun Pharmaceutical Industries Inc.1$57
Iovance Biotherapeutics, Inc.2$56
Genmab U.S., Inc.2$56
Deciphera Pharmaceuticals Inc.3$50
ADC Therapeutics America, Inc.3$50
Morphosys, US Inc.3$49
Blue Earth Diagnostics2$43
Legend Biotech USA Inc.1$39
EUSA Pharma (US) LLC2$36

How this compares

$99,891 in reported general payments places this provider in the 75th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$394,040
Medicare patients
1,210
Services billed
4,254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Hilton Head Island

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →